Abstract:Laparoscopic fundoplication can be safely performed in infants. There was no predictor of recurrence. However, there is a 20% late mortality in patients with severe co-morbidities, which needs to be taken into account when counseling patients.
“…Published outcomes of laparoscopic Nissen fundoplication in infants and neonate age group were limited. Several studies advocated safety and feasibility of laparoscopic fundoplication in infants [6][7][8]. Other studies argued against the safety of this operation in neonates.…”
Section: Discussionmentioning
confidence: 99%
“…Data on laparoscopic Nissen fundoplication for GERD in infants remain limited. Some studies demonstrated its safety and efficacy in infants, [6][7][8] whereas other showed a higher incidence of intra-operative complications in infants weighing less than 5 kg [9]. We describe our experience with this operation in children and in particular, infants younger than 12 months old.…”
Laparoscopic Nissen fundoplication can be safely performed in infants with outcomes comparable to older patients and a shorter operative duration. Low recurrence rate (up to 3 %) is shown by our long term follow-up data. We recommend laparoscopic Nissen fundoplication to be considered in managing infants with GERD.
“…Published outcomes of laparoscopic Nissen fundoplication in infants and neonate age group were limited. Several studies advocated safety and feasibility of laparoscopic fundoplication in infants [6][7][8]. Other studies argued against the safety of this operation in neonates.…”
Section: Discussionmentioning
confidence: 99%
“…Data on laparoscopic Nissen fundoplication for GERD in infants remain limited. Some studies demonstrated its safety and efficacy in infants, [6][7][8] whereas other showed a higher incidence of intra-operative complications in infants weighing less than 5 kg [9]. We describe our experience with this operation in children and in particular, infants younger than 12 months old.…”
Laparoscopic Nissen fundoplication can be safely performed in infants with outcomes comparable to older patients and a shorter operative duration. Low recurrence rate (up to 3 %) is shown by our long term follow-up data. We recommend laparoscopic Nissen fundoplication to be considered in managing infants with GERD.
“…Yineleyen aspirasyon pnömonisi, apne atakları, bradikardi ve yaşamı tehdit eden olayların gerçekleşmesi, bronkopulmoner displazi, ciddi kusma ve büyüme geriliği, özofajit ya da özofagus darlığı (yenidoğan ve bebeklerde ender) cerrahi endikasyonudur (1,16) .…”
Section: Tedaviunclassified
“…Ameliyat sonrasında sıklıkla gastrostomi ile ilişkili komplikasyonlara rastlanırken, kesi yeri enfeksiyonu, karın içi abse, darlık, bağırsak tıkanıklıkları, dumping sendromu, öğürme, gas-bloat, disfaji, nüks, pnömoni görülebilir (6,7,9,10,16) .…”
Section: Tedaviunclassified
“…Literatürde yenidoğan ve bebeklik çağında yapılan fundoplikasyonlar sonrası yine fundoplikasyon gereksiniminin diğer yaşlara göre yüksek olduğuna dair makaleler mevcuttur (8,10,16) . Teknikten bağımsız olarak bu oran %7-26 arasında değişmektedir (1) .…”
Summary
Gastroesophageal reflux may exacerbate lung disease in infants with bronchopulmonary dysplasia (BPD). Anti-reflux surgery may therefore reduce the severity of this disease in some infants. We report a retrospective series of 22 infants with severe BPD who underwent anti-reflux surgery. Our experience indicates that these procedures can be safely performed in this population and that early post-operative initiation of gastric feeds is well tolerated. Modest post-operative reductions in required oxygen and median respiratory rate were observed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.